The Astellas European Foundation has announced the shortlist for the 2014 Uro-Oncology Grant. The Grant programme supports basic medical and related scientific programmes which contribute to advancements in urological oncology. The five finalists include applications from The Netherlands, Portugal and Spain. The winner will be announced at an event in Madrid, Spain, on 27th September.
The Astellas European Foundation is a registered charity with the long-term goal of providing support for programmes and activities that advance our understanding of medicine and health. The winner of the Grant is selected by a Judging Faculty that includes independent European thought leaders.
The shortlist includes teams led by:
Professor Paula Videira, Nova University, Lisbon, Portugal
Dr. Wim Witjes, EAU Research Foundation, EAU Central Research Office, Arnhem, Netherlands
Dr. Gabri van der Pluijm, Leiden University Medical Centre, The Netherlands
Professor António Araújo, Portuguese Institute of Oncology, Porto, Portugal
Dr Alvaro Aytes and Dr Josep Piulats, L'Hospitalet del Llobregat, Barcelona, Spain
Dr Ayad Abdulahad, Astellas European Foundation Trustee and Senior Vice President of Medical Affairs and Health Economics for Astellas Pharma EMEA, commented, "We have received enormous interest in the Grant, and this year alone we accepted 60 high-quality entries from research institutions and hospitals across Europe and also from South Africa. The Foundation looks forward to announcing the winner on Saturday, and is pleased to share the shortlist entrants who have succeeded in reaching the final stage."
The Foundation now offers annual Grants of $150,000 for Uro-Oncology, Functional Urology and Uro-Gynaecology, and Transplantation.